S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
Log in

The Chemours Stock Forecast, Price & News

-0.35 (-1.22 %)
(As of 01/20/2021 04:43 PM ET)
Today's Range
Now: $28.35
50-Day Range
MA: $26.47
52-Week Range
Now: $28.35
Volume980,780 shs
Average Volume1.28 million shs
Market Capitalization$4.66 billion
P/E RatioN/A
Dividend Yield3.48%
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Fluoroproducts, Chemical Solutions, and Titanium Technologies. The Fluoroproducts segment offers fluorochemicals, including refrigerants, foam blowing agents, and propellants under the Freon and Opteon brand names; fluoropolymers, such as industrial resins, specialty products, and coatings under the Teflon, Viton, Krytox, and Nafion brands; and fluoroelastomer products under the Viton brand name for electronics, communications, automotive, wire and cable, energy, oil and gas, aerospace, and other applications. The Chemical Solutions segment provides industrial and specialty chemicals for gold production, consumer, plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining industries. The Titanium Technologies segment manufactures and sells titanium dioxide pigments under the Ti-Pure and BaiMax brands for applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers, and coated papers and paperboards used for packaging. It sell its products through direct channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
The Chemours logo


Overall MarketRank

2.10 out of 5 stars

Basic Materials Sector

29th out of 812 stocks

Chemicals & Allied Products Industry

2nd out of 30 stocks

Analyst Opinion: 2.2Community Rank: 2.3Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Chemicals & allied products



Sales & Book Value

Annual Sales$5.53 billion
Cash Flow$4.73 per share
Book Value$4.25 per share


Net Income$-52,000,000.00


Market Cap$4.66 billion
Next Earnings Date2/11/2021 (Estimated)
-0.35 (-1.22 %)
(As of 01/20/2021 04:43 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

The Chemours (NYSE:CC) Frequently Asked Questions

How has The Chemours' stock price been impacted by COVID-19 (Coronavirus)?

The Chemours' stock was trading at $10.66 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CC stock has increased by 165.9% and is now trading at $28.35.
View which stocks have been most impacted by COVID-19

Is The Chemours a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Chemours in the last twelve months. There are currently 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" The Chemours stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View analyst ratings for The Chemours
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than The Chemours?

Wall Street analysts have given The Chemours a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but The Chemours wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Thomas Greco's approval rating as The Chemours' CEO?

538 employees have rated The Chemours CEO Thomas Greco on Glassdoor.com. Thomas Greco has an approval rating of 63% among The Chemours' employees. This puts Thomas Greco in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is The Chemours' next earnings date?

The Chemours is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for The Chemours

How were The Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) issued its quarterly earnings data on Sunday, November, 8th. The specialty chemicals company reported $0.47 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.33 by $0.14. The specialty chemicals company earned $1.23 billion during the quarter, compared to analysts' expectations of $1.20 billion. The Chemours had a negative net margin of 2.35% and a positive return on equity of 46.27%. The company's quarterly revenue was down 11.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.59 EPS.
View The Chemours' earnings history

How often does The Chemours pay dividends? What is the dividend yield for The Chemours?

The Chemours declared a quarterly dividend on Wednesday, October 28th. Investors of record on Monday, November 16th will be given a dividend of $0.25 per share on Wednesday, December 16th. This represents a $1.00 annualized dividend and a yield of 3.53%. The ex-dividend date of this dividend is Friday, November 13th.
View The Chemours' dividend history

Is The Chemours a good dividend stock?

The Chemours pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.48%. The dividend payout ratio of The Chemours is 39.84%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, The Chemours will have a dividend payout ratio of 37.31% next year. This indicates that The Chemours will be able to sustain or increase its dividend.
View The Chemours' dividend history.

What price target have analysts set for CC?

10 equities research analysts have issued 12 month price objectives for The Chemours' shares. Their forecasts range from $11.00 to $35.00. On average, they anticipate The Chemours' share price to reach $22.30 in the next year. This suggests that the stock has a possible downside of 21.3%.
View analysts' price targets for The Chemours
or view Wall Street analyst' top-rated stocks.

Who are some of The Chemours' key competitors?

What other stocks do shareholders of The Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).

Who are The Chemours' key executives?

The Chemours' management team includes the following people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 63, Pay $1.18M)
  • Mr. Sameer Ralhan, Sr. VP & CFO (Age 47, Pay $505.44k)
  • Mr. Mark E. Newman, Sr. VP & COO (Age 58, Pay $734.64k)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 57, Pay $577.65k)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 64, Pay $702.63k)
  • Mr. Edwin C. Sparks, Pres of Chemical Solutions & Fluoroproducts (Age 47, Pay $694.98k)
  • Mr. Matthew S. Abbott, VP, Chief Accounting Officer & Controller (Age 45)
  • Mr. Jonathan Lock, VP of Corp. Devel. & Investor Relations
  • Ms. Alvenia Scarborough, Sr. VP of Corp. Communications & Chief Brand Officer
  • Ms. Susan M. Kelliher, Sr. VP of People & Health Services (Age 54)

What is The Chemours' stock symbol?

The Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

Who are The Chemours' major shareholders?

The Chemours' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include DNB Asset Management AS (0.50%), CHURCHILL MANAGEMENT Corp (0.18%), State of Alaska Department of Revenue (0.02%), Lavaca Capital LLC (0.01%), Measured Wealth Private Client Group LLC (0.01%) and Crossmark Global Holdings Inc. (0.01%). Company insiders that own The Chemours stock include Amy Trojanowski, Bradley J Bell, David C Shelton, E Bryan Snell, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mary B Cranston, Paul Kirsch, Richard H Brown and Susan M Kelliher.
View institutional ownership trends for The Chemours

Which institutional investors are selling The Chemours stock?

CC stock was sold by a variety of institutional investors in the last quarter, including CHURCHILL MANAGEMENT Corp, Crossmark Global Holdings Inc., and State of Alaska Department of Revenue. Company insiders that have sold The Chemours company stock in the last year include Edwin C Sparks, and Mark P Vergnano.
View insider buying and selling activity for The Chemours
or view top insider-selling stocks.

Which institutional investors are buying The Chemours stock?

CC stock was purchased by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Lavaca Capital LLC, FNY Investment Advisers LLC, and Measured Wealth Private Client Group LLC. Company insiders that have bought The Chemours stock in the last two years include Bradley J Bell, David C Shelton, E Bryan Snell, Mark Newman, Mark P Vergnano, Mary B Cranston, Richard H Brown, and Susan M Kelliher.
View insider buying and selling activity for The Chemours
or or view top insider-buying stocks.

How do I buy shares of The Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is The Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $28.35.

How big of a company is The Chemours?

The Chemours has a market capitalization of $4.66 billion and generates $5.53 billion in revenue each year. The specialty chemicals company earns $-52,000,000.00 in net income (profit) each year or $2.51 on an earnings per share basis. The Chemours employs 7,000 workers across the globe.

What is The Chemours' official website?

The official website for The Chemours is www.chemours.com.

How can I contact The Chemours?

The Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.